- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Sanofi top pharmaceutical products 2017-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Sanofi top pharmaceutical products 2017-2018
Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)
by Matej Mikulic,
last edited
Aug 9, 2019
Lantus was Sanofi’s best-selling pharmaceutical product in 2018 according to the company’s latest annual financial report. The long-acting insulin (glargine), used to treat diabetes type I and II, generated nearly 3.6 billion U.S. dollars worldwide. Lantus has been among the company’s top products for many years but has shown significant decrease in revenue since the patent expired during 2015. In 2016, Sanofi introduced a much more potent formulation of insulin glargine under the brand name Toujeo.
Diabetes treatment
Diabetes is one of the most prevalent chronic diseases worldwide. Accordingly, antidiabetics form one of the three largest therapy classes within the global pharmaceutical market. Diabetes means that the human body is not able to produce its own insulin or use its insulin effectively. While persons with type 1 diabetes always need insulin for treatment, diabetes type 2 patients do not necessarily need it. A key medicine for persons with type 2 diabetes is metformin which helps to control blood sugar and to use insulin effectively. Change in lifestyle, a balanced diet, and physical activity might also be important parts of diabetes treatment.
The diabetes market
As mentioned, the diabetes segment is one of the largest single therapy classes within the pharmaceutical market, generating over 72 billion U.S. dollars in 2017. With projected increasing numbers of people affected worldwide until 2045, the diabetes market is also expected to grow. Currently, French company Sanofi is the world’s second largest antidiabetics manufacturing company based on revenue, only topped by Danish company Novo Nordisk. It is expected that Novo Nordisk will extend its market share in the diabetes sector up to 35 percent until 2024, thus maintaining the global leading position.
Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)
| 2017 | 2018 | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| 2017 | 2018 | |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 9, 2019
Lantus was Sanofi’s best-selling pharmaceutical product in 2018 according to the company’s latest annual financial report. The long-acting insulin (glargine), used to treat diabetes type I and II, generated nearly 3.6 billion U.S. dollars worldwide. Lantus has been among the company’s top products for many years but has shown significant decrease in revenue since the patent expired during 2015. In 2016, Sanofi introduced a much more potent formulation of insulin glargine under the brand name Toujeo.
Diabetes treatment
Diabetes is one of the most prevalent chronic diseases worldwide. Accordingly, antidiabetics form one of the three largest therapy classes within the global pharmaceutical market. Diabetes means that the human body is not able to produce its own insulin or use its insulin effectively. While persons with type 1 diabetes always need insulin for treatment, diabetes type 2 patients do not necessarily need it. A key medicine for persons with type 2 diabetes is metformin which helps to control blood sugar and to use insulin effectively. Change in lifestyle, a balanced diet, and physical activity might also be important parts of diabetes treatment.
The diabetes market
As mentioned, the diabetes segment is one of the largest single therapy classes within the pharmaceutical market, generating over 72 billion U.S. dollars in 2017. With projected increasing numbers of people affected worldwide until 2045, the diabetes market is also expected to grow. Currently, French company Sanofi is the world’s second largest antidiabetics manufacturing company based on revenue, only topped by Danish company Novo Nordisk. It is expected that Novo Nordisk will extend its market share in the diabetes sector up to 35 percent until 2024, thus maintaining the global leading position.
- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- This statistic was assembled from several financial reports.
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- This statistic was assembled from several financial reports.
Other statistics on the topic
Top pharmaceutical drugs
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
Pharmaceutical Products & Market
Revenue of Sanofi 2006-2018
+Pharmaceutical Products & Market
Sanofi number of employees 2009-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Sanofi
- 47 page/s
- English
- pptx
- Detailed references
Everything On "Sanofi" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Sanofi"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 pharmaceutical companies based on global prescription drug revenue in 2024 (in billion U.S. dollars)*Total global prescription drug revenue from top 10 companies 2024
- Top 5 global vaccine products by market share in 2017 and 2024Leading global vaccine products by market share 2017 and 2024
- Top animal health mergers and acquisitions worldwide between 2014 and 2018, by enterprise value (in million U.S. dollars)Top global mergers and acquisitions in animal health 2014-2018, by enterprise value
- Overview
The most important statistics
- Revenue of Sanofi from 2006 to 2018 (in million euros)Revenue of Sanofi 2006-2018
- Sanofi's selected top pharmaceutical products based on revenue in 2017 and 2018 (in million euros)Sanofi top pharmaceutical products 2017-2018
- Sanofi's net income from 2007 to 2018 (in million euros)*Sanofi's net income 2007-2018
- Sanofi's expenditure on research and development from 2008 to 2018 (in million euros)Sanofi's expenditure on research and development 2008-2018
- Sanofi's total assets from 2007 to 2018 (in million euros)Sanofi's total assets 2007-2018
- Sanofi's number of employees from 2009 to 2018Sanofi number of employees 2009-2018
- Revenue distribution
The most important statistics
- Revenue of Sanofi by region in 2018 (in million euros)Sanofi revenue by region 2018
- Revenue of Sanofi by segment from 2014 to 2018 (in million euros)Sanofi - revenue by segment 2014-2018
- Revenue of Sanofi's pharmaceutical segment by product group from 2015 to 2018 (in million euros)Sanofi - pharmaceutical segment revenues by product group 2015-2018
- Sanofi's human vaccine revenues from 2016 to 2018, by area of application (in million euros)Sanofi: human vaccine revenues 2016-2018
- Revenue of Sanofi 's Animal Health segment from 2012 to 2016 (in million euros)Sanofi - revenue of animal health segment 2012-2016
- Company shares
The most important statistics
- Number of Sanofi's outstanding shares from 2009 to 2018 (in millions)Average number of outstanding shares of Sanofi 2009-2018
- Basic earning's per Sanofi's shares from 2009 to 2018 (in euros)Basic earnings per share of Sanofi 2009-2018
- Cash dividend per share of Sanofi from 2009 to 2018 (in euros)*Cash dividend per share of Sanofi 2009-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Boehringer Ingelheim's top self-medication drugs revenues 2008-2016
- Industry turnover for leading pharmaceuticals German 2017
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Willingness of Chinese consumers to pay more for international medicine brands 2013
- Sales revenue of medicaments via physical retail pharmacies in China 2011-2018
- Number of pharmaceuticals on China's national reimbursement drug list
- Channel distribution of U.S. dispensed prescriptions 2017 and 2018
- Retail sales of pharmaceuticals in China by month 2011-2019
- European medicines market share by country 2011-2015
- RAS-acting agents pharmaceutical consumption in Spain 2004-2017
- E-commerce purchase channels of drugstore products in the Netherlands 2018
- Export value of medicinal and pharmaceutical products from China 2017
- Pharmaceutical R&D expenditure by therapeutic area Worldwide 2015
- Quarterly number of users of antidepressants in Denmark 2017-2018
- United Kingdom (UK): pharmaceutical products export value to Germany 2012-2018
- United Kingdom (UK): pharmaceutical products import value from Germany 2012-2018
- Antibacterials for systemic use: consumption in Lithuania 2017
Studies
- Pharmaceutical industry in India
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical trends in Europe
- Dechra Pharmaceuticals PLC Annual Report 2018
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical industry in Italy
- The Controversey over Rising Drug Prices: The Public's View
- Celgene Corporation - 2018 Form 10-K
- The 2019 Genentech Oncology Trend Report
- Sobi Anual and sustainability report 2017
- Biogen Inc. - 2018 Form 10-K
- Teva - 2018 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
Statistics on "Sanofi"
- Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Total global prescription drug revenue from top 10 companies 2024
- Leading global vaccine products by market share 2017 and 2024
- Top global mergers and acquisitions in animal health 2014-2018, by enterprise value
- Revenue of Sanofi 2006-2018
- Sanofi top pharmaceutical products 2017-2018
- Sanofi's net income 2007-2018
- Sanofi's expenditure on research and development 2008-2018
- Sanofi's total assets 2007-2018
- Sanofi number of employees 2009-2018
- Sanofi revenue by region 2018
- Sanofi - revenue by segment 2014-2018
- Sanofi - pharmaceutical segment revenues by product group 2015-2018
- Sanofi: human vaccine revenues 2016-2018
- Sanofi - revenue of animal health segment 2012-2016
- Average number of outstanding shares of Sanofi 2009-2018
- Basic earnings per share of Sanofi 2009-2018
- Cash dividend per share of Sanofi 2009-2018
- Boehringer Ingelheim's top self-medication drugs revenues 2008-2016
- Industry turnover for leading pharmaceuticals German 2017
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Willingness of Chinese consumers to pay more for international medicine brands 2013
- Sales revenue of medicaments via physical retail pharmacies in China 2011-2018
- Number of pharmaceuticals on China's national reimbursement drug list
- Channel distribution of U.S. dispensed prescriptions 2017 and 2018
- Retail sales of pharmaceuticals in China by month 2011-2019
- European medicines market share by country 2011-2015
- RAS-acting agents pharmaceutical consumption in Spain 2004-2017
- E-commerce purchase channels of drugstore products in the Netherlands 2018
- Export value of medicinal and pharmaceutical products from China 2017
- Pharmaceutical R&D expenditure by therapeutic area Worldwide 2015
- Quarterly number of users of antidepressants in Denmark 2017-2018
- United Kingdom (UK): pharmaceutical products export value to Germany 2012-2018
- United Kingdom (UK): pharmaceutical products import value from Germany 2012-2018
- Antibacterials for systemic use: consumption in Lithuania 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.